Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun 10;10(3):e104900.
doi: 10.5812/aapm.104900. eCollection 2020 Jun.

Management of Critically Ill Patients with COVID-19: What We Learned and What We Do

Ata Mahmoodpoor  1 , Kamran Shadvar  1 , Ali Akbar Ghamari  1 , Mojtaba Mohammadzadeh Lameh  1 , Roghayeh Asghari Ardebili  1 , Masood Hamidi  1 , Hassan Soleimanpour  2
Affiliations

Management of Critically Ill Patients with COVID-19: What We Learned and What We Do

Ata Mahmoodpoor et al. Anesth Pain Med. .

Abstract

There are many unknown questions and puzzle pieces that should describe the clinical course of COVID-19 and its complications, especially ARDS. We provide the initial immediate surge response to allow every patient in need of an ICU bed to receive one. Till our knowledge is improved, the most important intervention in the treatment of critically ill patients with COVID-19 seems to be the level of standard care and appropriate and early diagnosis and treatment. It seems that each center should have its protocol on the management of critically ill COVID-19 patients regarding prevention, diagnosis, and treatment. This treatment should now be performed regardless of the reason which lies behind the pathophysiology of this disease, which is yet unknown. In this report, we share our experience in the management of critically ill COVID-19 patients during the 2 months in our intensive care unit.

Keywords: Acute Respiratory Distress Syndrome; COVID-19; Corticosteroid; Critically Ill Patients; Hemoperfusion; Hydroxychloroquine.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interests: Authors declare no conflict of interest.

Figures

Figure 1.
Figure 1.. Treatment protocol of critically ill Covid-19 patients admitted to ICU
See this image and copyright information in PMC

References

    1. Murthy S, Gomersall CD, Fowler RA. Care for Critically Ill Patients With COVID-19. JAMA. 2020 doi: 10.1001/jama.2020.3633. - DOI - PubMed
    1. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020 doi: 10.1001/jama.2020.2648. - DOI - PubMed
    1. Fardet L, Galicier L, Lambotte O, Marzac C, Aumont C, Chahwan D, et al. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol. 2014;66(9):2613–20. doi: 10.1002/art.38690. - DOI - PubMed
    1. Shen C, Wang Z, Zhao F, Yang Y, Li J, Yuan J, et al. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma. JAMA. 2020 doi: 10.1001/jama.2020.4783. - DOI - PMC - PubMed
    1. Gattinoni L, Chiumello D, Caironi P, Busana M, Romitti F, Brazzi L, et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Medicine. 2020 doi: 10.1007/s00134-020-06033-2. - DOI - PMC - PubMed

LinkOut - more resources